PMID- 27479079 OWN - NLM STAT- MEDLINE DCOM- 20170822 LR - 20181113 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 11 IP - 8 DP - 2016 TI - Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel Binding. PG - e0159529 LID - 10.1371/journal.pone.0159529 [doi] LID - e0159529 AB - To fully understand the glycolytic behavior of cancer cells, it is important to recognize how it is linked to pH dynamics. Here, we evaluated the acute effects of mild acidification and alkalization on cancer cell glucose uptake and glycolytic flux and investigated the role of hexokinase (HK). Cancer cells exposed to buffers with graded pH were measured for 18F-fluorodeoxyglucose (FDG) uptake, lactate production and HK activity. Subcellular localization of HK protein was assessed by western blots and confocal microscopy. The interior of T47D breast cancer cells was mildly alkalized to pH 7.5 by a buffer pH of 7.8, and this was accompanied by rapid increases of FDG uptake and lactate extrusion. This shift toward glycolytic flux led to the prompt recovery of a reversed pH gradient. In contrast, mild acidification rapidly reduced cellular FDG uptake and lactate production. Mild acidification decreased and mild alkalization increased mitochondrial HK translocation and enzyme activity. Cells transfected with specific siRNA against HK-1, HK-2 and voltage-dependent anion channel (VDAC)1 displayed significant attenuation of pH-induced changes in FDG uptake. Confocal microscopy showed increased co-localization of HK-1 and HK-2 with VDAC1 by alkaline treatment. In isolated mitochondria, acidic pH increased and alkaline pH decreased release of free HK-1 and HK-2 from the mitochondrial pellet into the supernatant. Furthermore, experiments using purified proteins showed that alkaline pH promoted co-immunoprecipitation of HK with VDAC protein. These findings demonstrate that mild alkalization is sufficient to acutely trigger cancer cell glycolytic flux through enhanced activity of HK by promoting its mitochondrial translocation and VDAC binding. This process might serve as a mechanism through which cancer cells trigger the Warburg effect to maintain a dysregulated pH. FAU - Quach, Cung Hoa Thien AU - Quach CH AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. FAU - Jung, Kyung-Ho AU - Jung KH AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. AD - Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea. FAU - Lee, Jin Hee AU - Lee JH AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. AD - Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea. FAU - Park, Jin Won AU - Park JW AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. AD - Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea. FAU - Moon, Seung Hwan AU - Moon SH AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. FAU - Cho, Young Seok AU - Cho YS AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. FAU - Choe, Yearn Seong AU - Choe YS AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. AD - Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea. FAU - Lee, Kyung-Han AU - Lee KH AD - Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea. AD - Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea. LA - eng PT - Journal Article DEP - 20160801 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (RNA, Small Interfering) RN - 0 (VDAC1 protein, human) RN - 0Z5B2CJX4D (Fluorodeoxyglucose F18) RN - 33X04XA5AT (Lactic Acid) RN - EC 1.6.- (Voltage-Dependent Anion Channel 1) RN - EC 2.7.1.1 (HK1 protein, human) RN - EC 2.7.1.1 (Hexokinase) SB - IM MH - Cell Line, Tumor MH - Fluorodeoxyglucose F18/metabolism MH - Glycolysis MH - Hexokinase/antagonists & inhibitors/genetics/*metabolism MH - Humans MH - Hydrogen-Ion Concentration MH - Immunoprecipitation MH - Lactic Acid/metabolism MH - Microscopy, Confocal MH - Mitochondria/metabolism MH - Protein Binding MH - RNA Interference MH - RNA, Small Interfering/metabolism MH - Voltage-Dependent Anion Channel 1/antagonists & inhibitors/genetics/*metabolism PMC - PMC4968818 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2016/08/02 06:00 MHDA- 2017/08/23 06:00 PMCR- 2016/08/01 CRDT- 2016/08/02 06:00 PHST- 2016/02/22 00:00 [received] PHST- 2016/07/05 00:00 [accepted] PHST- 2016/08/02 06:00 [entrez] PHST- 2016/08/02 06:00 [pubmed] PHST- 2017/08/23 06:00 [medline] PHST- 2016/08/01 00:00 [pmc-release] AID - PONE-D-16-07528 [pii] AID - 10.1371/journal.pone.0159529 [doi] PST - epublish SO - PLoS One. 2016 Aug 1;11(8):e0159529. doi: 10.1371/journal.pone.0159529. eCollection 2016.